| 摘要 |
<p>The present invention provides a pharmaceutical composition comprising atovaquone and a non-protein pulmonary surfactant. Suitably the composition comprises 10 to 30 % atovaquone by weight and 70 to 90 % non-protein pulmonary surfactant. The composition is suitable for oral or pulmonary administration and provides atovaquone having improved bioavailability.</p> |
